Q: My 62-year-old aunt recently was hospitalized for something called broken heart syndrome, where seemingly healthy people have heart attacks after traumatic events. What is this, and what do doctors ...

U.S. regulators approved a label expansion for Novo Nordisk’s obesity drug Wegovy to tout its benefits for the heart, a move that could boost demand and insurance coverage for the already highly ...

Wegovy® recommended by the European regulatory authorities for label update to reflect reduced heart failure symptoms and improved physical function Wegovy® (semaglutide 2.4 mg) is the first obesity ...